Orion
Geula Jaffe, MPH, is an accomplished executive with extensive experience in the biopharmaceutical industry, currently serving as Chief Commercial Officer, Innovative Medicines at Orion Pharma since May 2025. Previously, Geula held leadership roles at AbbVie and ImmunoGen, overseeing the global life cycle development of the ELAHERE™ program for ovarian cancer. Geula founded Apogene Consulting, providing strategic product development and marketing consultations, and has contributed significantly in various senior positions including Vice President Marketing at Novocure and Head of Oncology & Hematology Strategic Engagement at GSK. Educated at Yale University with a Master of Public Health and New York University with a BA in Economics, Geula also spent time on a family sabbatical traveling globally before furthering a successful career in oncology and hematology.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.